2014 Q2 Form 10-Q Financial Statement

#000095015914000415 Filed on August 18, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2014
Revenue $6.230M $3.608M $21.07M
YoY Change -12.21% -63.76% -35.12%
Cost Of Revenue $6.012M $6.260M $21.80M
YoY Change -9.95% -24.76% -15.88%
Gross Profit $218.2K -$2.651M -$731.8K
YoY Change -48.07% -262.54% -111.16%
Gross Profit Margin 3.5% -73.48% -3.47%
Selling, General & Admin $1.329M $1.420M $6.113M
YoY Change -24.93% -26.8% -25.1%
% of Gross Profit 608.86%
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $255.6K $230.0K $953.4K
YoY Change 0.71% 0.0% 12.7%
% of Gross Profit 117.14%
Operating Expenses $1.329M $1.420M $6.113M
YoY Change -24.93% -27.18% -25.1%
Operating Profit -$1.111M -$4.071M -$6.845M
YoY Change -17.73% 1176.18% 327.15%
Interest Expense $160.6K -$220.0K $440.6K
YoY Change 129.0% 144.44% 42.23%
% of Operating Profit
Other Income/Expense, Net -$160.5K $20.00K -$436.2K
YoY Change 116.75% 29.35%
Pretax Income -$1.271M -$4.280M -$7.281M
YoY Change -10.73% 943.9% 275.38%
Income Tax $0.00 -$190.0K -$185.5K
% Of Pretax Income
Net Earnings -$1.270M -$4.100M -$7.100M
YoY Change -10.56% 266.07% 194.61%
Net Earnings / Revenue -20.38% -113.64% -33.7%
Basic Earnings Per Share -$0.05 -$0.19 -$0.34
Diluted Earnings Per Share -$0.05 -$0.19 -$0.34
COMMON SHARES
Basic Shares Outstanding 24.01M shares 20.77M shares
Diluted Shares Outstanding 24.01M shares 20.77M shares

Balance Sheet

Concept 2014 Q2 2014 Q1 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $890.0K $1.090M $1.090M
YoY Change -63.52% -64.61% -64.61%
Cash & Equivalents $886.9K $1.087M $1.090M
Short-Term Investments
Other Short-Term Assets $457.2K $461.2K $1.460M
YoY Change -68.17% -70.78% -20.22%
Inventory $4.940M $5.550M $5.550M
Prepaid Expenses
Receivables $3.221M $2.280M $2.280M
Other Receivables $10.00K $10.00K $10.00K
Total Short-Term Assets $10.50M $10.38M $10.38M
YoY Change -12.06% -27.25% -27.26%
LONG-TERM ASSETS
Property, Plant & Equipment $6.328M $6.489M $6.490M
YoY Change -10.98% -11.11% -11.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.5K $105.4K $110.0K
YoY Change
Total Long-Term Assets $6.728M $6.595M $6.590M
YoY Change -5.35% -9.67% -9.73%
TOTAL ASSETS
Total Short-Term Assets $10.50M $10.38M $10.38M
Total Long-Term Assets $6.728M $6.595M $6.590M
Total Assets $17.23M $16.97M $16.97M
YoY Change -9.55% -21.3% -21.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.810M $2.888M $2.890M
YoY Change 294.32% 13.85% 13.78%
Accrued Expenses $3.816M $3.893M $400.0K
YoY Change 56.58% 107.64% -67.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due $5.580M $4.170M $4.170M
YoY Change -0.53% -27.85% -27.85%
Total Short-Term Liabilities $13.86M $12.41M $12.41M
YoY Change 40.71% 11.0% 11.0%
LONG-TERM LIABILITIES
Long-Term Debt $40.00K $40.00K $40.00K
YoY Change 33.33% 33.33% 33.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $40.00K $40.00K $40.00K
YoY Change 33.33% 33.33% 33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.86M $12.41M $12.41M
Total Long-Term Liabilities $40.00K $40.00K $40.00K
Total Liabilities $14.89M $13.40M $13.44M
YoY Change 46.84% 16.83% 17.18%
SHAREHOLDERS EQUITY
Retained Earnings -$4.436M -$3.165M
YoY Change -277.0% -180.53%
Common Stock $2.467K $2.395K
YoY Change 23.6% 19.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.342M $3.531M $3.530M
YoY Change
Total Liabilities & Shareholders Equity $17.23M $16.97M $16.97M
YoY Change -9.55% -21.3% -21.33%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2014
OPERATING ACTIVITIES
Net Income -$1.270M -$4.100M -$7.100M
YoY Change -10.56% 266.07% 194.61%
Depreciation, Depletion And Amortization $255.6K $230.0K $953.4K
YoY Change 0.71% 0.0% 12.7%
Cash From Operating Activities -$1.560M -$1.620M $200.0K
YoY Change 280.49% -243.36% -88.76%
INVESTING ACTIVITIES
Capital Expenditures $54.09K -$10.00K $64.90K
YoY Change -4.13% -96.15% -90.21%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$50.00K -$10.00K -$60.00K
YoY Change -16.67% -96.15% -90.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.410M -1.030M -2.130M
YoY Change -929.41% -615.0% 144.83%
NET CHANGE
Cash From Operating Activities -1.560M -1.620M 200.0K
Cash From Investing Activities -50.00K -10.00K -60.00K
Cash From Financing Activities 1.410M -1.030M -2.130M
Net Change In Cash -200.0K -2.660M -1.990M
YoY Change -68.75% -348.6% -896.0%
FREE CASH FLOW
Cash From Operating Activities -$1.560M -$1.620M $200.0K
Capital Expenditures $54.09K -$10.00K $64.90K
Free Cash Flow -$1.614M -$1.610M $135.1K
YoY Change 246.06% -215.83% -87.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
105395 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
886888 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1271069 USD
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
505000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12326412 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5837200 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6052716 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6489212 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6327789 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12380505 USD
CY2014Q2 us-gaap Depreciation
Depreciation
215516 USD
CY2013Q2 us-gaap Depreciation
Depreciation
248440 USD
CY2014Q1 tpcs Cost Incurred On Uncompleted Contracts
CostIncurredOnUncompletedContracts
9960072 USD
CY2013Q1 tpcs Cost Incurred On Uncompleted Contracts
CostIncurredOnUncompletedContracts
6180839 USD
CY2014Q2 tpcs Cost Incurred On Uncompleted Contracts
CostIncurredOnUncompletedContracts
8161105 USD
CY2014 tpcs Cost Incurred On Uncompleted Contracts During Period
CostIncurredOnUncompletedContractsDuringPeriod
25579089 USD
CY2014Q2 tpcs Cost Incurred On Uncompleted Contracts During Period
CostIncurredOnUncompletedContractsDuringPeriod
4213134 USD
CY2014 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21799856 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6012101 USD
CY2014Q1 tpcs Billings On Uncompleted Contracts
BillingsOnUncompletedContracts
4702070 USD
CY2013Q1 tpcs Billings On Uncompleted Contracts
BillingsOnUncompletedContracts
1882546 USD
CY2014Q2 tpcs Billings On Uncompleted Contracts
BillingsOnUncompletedContracts
3465067 USD
CY2014 tpcs Billings On Contracts During Period
BillingsOnContractsDuringPeriod
23887587 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
21068063 USD
CY2014Q2 tpcs Billings On Contracts During Period
BillingsOnContractsDuringPeriod
4993338 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
6230341 USD
CY2014Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
4696038 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1461689 USD
CY2014Q1 us-gaap Prepaid Insurance
PrepaidInsurance
229727 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
79995 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3893028 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3815754 USD
CY2014Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6000000 USD
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q1 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
231783 USD
CY2014Q2 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
219359 USD
CY2014Q1 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
3259103 USD
CY2014Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
3114447 USD
CY2014Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
81723 USD
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24669958 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23951004 shares
CY2014Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
34984 USD
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
461245 USD
CY2014Q2 us-gaap Supplies
Supplies
140032 USD
CY2014Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
74944 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
457248 USD
CY2014Q2 us-gaap Accumulated Amortization Of Noncurrent Deferred Finance Costs
AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts
40129 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
105395 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
400493 USD
CY2014Q2 tpcs Provision For Loss On Customer Purchase Agreement
ProvisionForLossOnCustomerPurchaseAgreement
2400000 USD
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
320419 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
401953 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3300000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1355500 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1547006 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1355500 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1355500 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
943832 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.014
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.074
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.074
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.074
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
329025 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
22075 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
22075 USD
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
22075 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M25D
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M29D
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M29D
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M16D
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
271907 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P33M
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
178685 USD
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
621333 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
411668 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
178665 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
31000 shares
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.967
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.877
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.000
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.960
CY2014Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 item
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24010264 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19956871 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1423905 USD
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24010264 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19956871 shares
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2192220 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
506500 shares
CY2014Q2 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">NOTE 1 &#8212; DESCRIPTION OF BUSINESS</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">TechPrecision Corporation, or TechPrecision, is a custom manufacturer of large scale metal fabricated and machined precision components and equipment. We offer a full range of services required to transform metallic raw materials into precise finished products. We sell these finished products to customers in three main industry groups: naval/maritime, energy and precision industrial. These products are used in a variety of markets including the alternative energy, medical, nuclear, defense, commercial, and aerospace industries. TechPrecision is the parent company of Ranor,&#160;Inc., or Ranor, a Delaware corporation. On November&#160;4, 2010, TechPrecision announced it completed the formation of a wholly foreign owned enterprise (WFOE), under the laws of the People&#8217;s Republic of China, Wuxi Critical Mechanical Components Co.,&#160;Ltd., or WCMC, to meet demand for local manufacturing of components in China. TechPrecision, WCMC and Ranor are collectively referred to as &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our.&#8221;</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Liquidity and Capital Resources</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At March&#160;31, 2013, we were not in compliance with the fixed charges and interest coverage financial covenants under our Loan and Security Agreement between Ranor and Santander Bank, or the Bank, dated February&#160;24, 2006, as amended, or the Loan Agreement, and the Bank did not agree to waive the non-compliance with the covenants. Since we were in default, the Bank had the right to accelerate payment of the debt in full upon 60 days written notice.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On May&#160;30, 2014, TechPrecision and Ranor entered into a Loan and Security Agreement, or the LSA, with Utica Leasco, LLC, or Utica. Pursuant to the LSA, Utica agreed to loan $4.15 million to Ranor under a Credit Loan Note, which is collateralized by a first secured interest in certain machinery and equipment at Ranor.&#160;&#160;Payments under the LSA and Credit Loan Note are due in monthly installments with interest on the unpaid principal balance of the Credit Loan Note at an interest rate equal to 7.5% plus the greater of 3.3% and the six-month LIBOR interest rate, as described in the Credit Loan Note. Ranor&#8217;s obligations under the LSA and the Credit Loan Note are guaranteed by TechPrecision.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Pursuant to the LSA, Ranor is subject to certain restrictive covenants which, among other things, restrict Ranor&#8217;s ability to (1)&#160;declare or pay any dividend or other distribution on its equity, purchase or retire any of its equity, or alter its capital structure; (2)&#160;make any loan or guaranty or assume any obligation or liability; (3)&#160;default in payment of any debt in excess of $5,000 to any person; (4)&#160;sell any of the collateral outside the normal course of business or (5)&#160;enter into any transaction that would materially or adversely affect the collateral or Ranor&#8217;s ability to repay the obligations under the LSA and the Credit Loan Note.&#160;&#160;The restrictions of these covenants are subject to certain exceptions specified in the LSA and in some cases may be waived by written consent of Utica.&#160;&#160;Any failure to comply with the&#160;covenants outlined in the LSA without waiver by Utica or certain other provisions in the LSA would be an event of default, pursuant to which Utica may accelerate the repayment of the loan.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In connection with the execution of the LSA, we paid approximately $0.24 million in fees and associated costs and utilized approximately $2.65 million to pay off debt obligations owed to the Bank, under the Loan Agreement.&#160;&#160;Additionally, the Company retained approximately $1.27 million for general corporate purposes.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On January&#160;16, 2014, we entered into a forbearance and modification agreement with the Bank, or the First Forbearance Agreement, in connection with the Loan Agreement. Under the First Forbearance Agreement, the Bank agreed to forbear from exercising certain of its rights and remedies arising as a result of the Company&#8217;s non-compliance with certain financial covenants under the Loan Agreement until March&#160;31, 2014.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">On May&#160;30, 2014, the Company and the Bank entered into a new forbearance and modification agreement, or the Second Forbearance Agreement. Under the Second Forbearance Agreement, the Bank agreed to forbear from exercising certain of its rights and remedies arising as a result of the Company&#8217;s non-compliance with certain financial covenants under the Loan Agreement commencing retroactively on April&#160;1, 2014 and extending until no later than June&#160;30, 2014, or the Second Forbearance Period.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">During the Second Forbearance Period, we agreed to comply with the terms, covenants and provisions in the Loan Agreement and related documents, as amended by the Second Forbearance Agreement.&#160;&#160;The Second Forbearance Agreement amends the Loan Agreement to, among other things, prohibit the Company&#8217;s Leverage Ratio&#160;&#160;(as such term is defined in the Loan Agreement) to be greater than 1.75 to 1.0.&#160;&#160;We were not in compliance with the leverage ratio covenant at June&#160;30, 2014 or at March&#160;31, 2014, as the actual leverage ratio was 4.3 to 1.0 and 3.8 to 1.0, respectively.</font> <font style="FONT-SIZE: 10pt;" size="2">The Second Forbearance Period was extended further subsequent to June&#160;30, 2014 pursuant to an execution of a new forbearance and modification agreement (see Note 18).</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Since we are in default, the Bank has the right to accelerate payment of the debt in full upon 60 days written notice. As a consequence, we classified $4.4 million (includes $3.1 million for Utica) and $3.7 million under the Loan Agreement, the Series&#160;A Bonds, the Series&#160;B Bonds, and the LSA, as applicable, as a current liability at June&#160;30, 2014 and March&#160;31, 2014.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In the event that we fail to pay off, or complete a refinancing of, the current outstanding obligations by the completion of the Second Forbearance Period (as extended by the forbearance and modification agreements entered into subsequent to June&#160;30, 2014 &#8212; see Note 18), the interest rate on outstanding obligations will convert to the default interest rate of 65% of the sum of one month Libor plus 16%. If the Bank were to demand full repayment, we would be unable to pay the obligation as we do not have existing facilities or sufficient cash on hand to satisfy these obligations and would need to seek alternative financing.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At June&#160;30, 2014, we had cash and cash equivalents of $886,888, of which $11,356 is located in China and which we may not be able to repatriate for use in the U.S. without undue cost or expense, if at all. Our cash and cash equivalents total includes $505,000 of restricted cash with the Bank that may be used toward funding operating activities with the Bank&#8217;s approval. Approximately 36% of our accounts receivable were at risk of not being paid in a timely manner due to a contract dispute with one of our customers. We have incurred an operating loss of $1.3 million for the three months ended June&#160;30, 2014. Our financial results for the past three years were impacted by significant new contract losses. We have recorded a provision for potential losses and, in one case, filed a demand for arbitration under a customer&#8217;s purchase agreement to recover all of our costs under the contract terms. We cannot be certain that we will be successful in recovering the full amount of our losses.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">These factors raise substantial doubt about our ability to continue as a going concern. In order for us to continue operations beyond the next twelve months and be able to discharge our liabilities and commitments in the normal course of business, we must secure long-term financing on terms consistent with our near-term business plans. In addition, we must increase our backlog and change the composition of our revenues to focus on recurring unit of delivery projects rather than custom first article and prototyping projects which do not efficiently use our manufacturing capacity, and reduce our operating expenses to be in line with current business conditions in order to increase profit margins and decrease the amount of cash used in operations. If successful in changing the composition of revenue and reducing costs, we anticipate that the year ending March&#160;31, 2015, or fiscal 2015 operating results will reflect positive cash flows. We plan to closely monitor our expenses and, if required, will further reduce operating costs to enhance liquidity.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The condensed consolidated financial statements for the three months ended June&#160;30, 2014 and the year ended March&#160;31, 2014, or fiscal 2014, were prepared on the basis of a going concern which contemplates that we will be able to realize assets and discharge liabilities in the normal course of business. Accordingly, they do not give effect to adjustments that would be necessary should we be required to liquidate assets. Our ability to satisfy our total current liabilities of $13.9 million at June&#160;30, 2014 and to continue as a going concern is dependent upon the availability of and our ability to timely secure long-term financing and the successful execution of an effective operating plan. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> </div>
CY2013Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13103 USD
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-809766 USD
CY2013Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-151355 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1557616 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-405061 USD
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54093 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1086701 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3220715 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2280469 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
242179 USD
CY2014Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
293326 USD
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8062 USD
CY2014Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8062 USD
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
991096 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
991096 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
10502226 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
10378901 USD
CY2014Q2 us-gaap Assets
Assets
17230508 USD
CY2014Q1 us-gaap Assets
Assets
16973508 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3810319 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2888385 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
5584459 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4169771 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13862455 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12412873 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
35278 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
38071 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
991096 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
991096 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
524210 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
644110 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
2467 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
2395 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6293864 USD
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6105211 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-42642 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-55097 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4436220 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3165151 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
2341679 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
3531468 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3613 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74066 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1423905 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-160536 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1271069 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-16680 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-110337 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17230508 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16973508 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25010 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25010 USD
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24669958 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23951004 shares
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
7096692 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6676449 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
218240 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
420243 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1328773 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1770082 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1110533 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1349839 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7552 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
160589 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
70127 USD
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
30 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
12455 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-2212 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-112549 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1258614 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1536454 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
255645 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
253833 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
68824 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
126092 USD
CY2014Q2 tpcs Provision For Contract Losses
ProvisionForContractLosses
366951 USD
CY2013Q2 tpcs Provision For Contract Losses
ProvisionForContractLosses
687088 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
940242 USD
CY2013Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-521202 USD
CY2014Q2 tpcs Increase Decrease In Costs Incurred On Uncompleted Contracts
IncreaseDecreaseInCostsIncurredOnUncompletedContracts
-561964 USD
CY2013Q2 tpcs Increase Decrease In Costs Incurred On Uncompleted Contracts
IncreaseDecreaseInCostsIncurredOnUncompletedContracts
-1047590 USD
CY2014Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-51153 USD
CY2013Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10175 USD
CY2014Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4001 USD
CY2013Q2 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-138184 USD
CY2014Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
335226 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
921933 USD
CY2013Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1580512 USD
CY2014Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-431784 USD
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-199813 USD
CY2013Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-630607 USD
CY2014Q2 us-gaap Interest Paid
InterestPaid
115056 USD
CY2013Q2 us-gaap Interest Paid
InterestPaid
64734 USD
CY2014Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
550000 shares
CY2013Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56424 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-54093 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-56424 USD
CY2014Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4150000 USD
CY2014Q2 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2738105 USD
CY2013Q2 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
172618 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1411895 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-172618 USD
CY2014Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
1 USD
CY2013Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3496 USD
CY2014Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
219359 USD
CY2014Q2 tpcs Tax On Liabilities Assumed
TaxOnLiabilitiesAssumed
0 USD
CY2013Q2 tpcs Tax On Liabilities Assumed
TaxOnLiabilitiesAssumed
0 USD
CY2014Q2 dei Entity Registrant Name
EntityRegistrantName
TECHPRECISION CORP
CY2014Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001328792
CY2014Q2 dei Document Type
DocumentType
10-Q
CY2014Q2 dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
CY2014Q2 dei Amendment Flag
AmendmentFlag
false
CY2014Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2014Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q2 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2014Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24669958 shares
CY2014Q2 tpcs Employee Agreement Annual Commitment For Future Salaries During Next Twelve Months
EmployeeAgreementAnnualCommitmentForFutureSalariesDuringNextTwelveMonths
1000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-29105 USD
CY2014Q2 tpcs Cash Deposits In Bank
CashDepositsInBank
11356 USD
CY2014Q2 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
440622 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2014Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4207842 USD
CY2014Q2 tpcs Contract Losses
ContractLosses
300000 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
11598 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
12313 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
9392 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
1975 USD
CY2014Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
5619737 USD
CY2014Q2 tpcs Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Yield Term Of Us Treasury Issues On Which Risk Free Interest Rate Is Based
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsYieldTermOfUSTreasuryIssuesOnWhichRiskFreeInterestRateIsBased
P5Y
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2444769 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3075376 USD
CY2013Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
278645 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5584459 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 tpcs Percentage Of Accounts Receivable At Risk Of Timely Payment Due To Contract Dispute
PercentageOfAccountsReceivableAtRiskOfTimelyPaymentDueToContractDispute
0.36 pure
CY2014Q2 tpcs Number Of Customer In Contact Dispute
NumberOfCustomerInContactDispute
1 item

Files In Submission

Name View Source Status
0000950159-14-000415-index-headers.html Edgar Link pending
0000950159-14-000415-index.html Edgar Link pending
0000950159-14-000415.txt Edgar Link pending
0000950159-14-000415-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex4-5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpcs-20140630.xml Edgar Link completed
tpcs-20140630.xsd Edgar Link pending
tpcs-20140630_cal.xml Edgar Link unprocessable
tpcs-20140630_def.xml Edgar Link unprocessable
tpcs-20140630_lab.xml Edgar Link unprocessable
tpcs-20140630_pre.xml Edgar Link unprocessable
tpcs10q.htm Edgar Link pending